The drug giant GlaxoSmithKline’s controversial diabetes drug Avandia (generic name rosiglitazone) works by helping diabetics balance their blood-sugar levels. But since its inception, it has been found to increase the risk of heart attacks and strokes — and even death.
As many as 100,000 heart attacks, strokes, deaths and cases of heart failure may be directly attributed to Avandia since the drug was launched in 1999, according to FDA scientist Dr. David Graham. Yet physicians are still prescribing the drug to nearly half a million people, which translates into approximately $900 million in annual sales for GSK. How has this been allowed to happen? Let’s take a look at the history of this potentially lethal but still-legal drug, courtesy of PBS: Continue reading
Just because a scientific paper sounds authoritative, it doesn’t mean we should always take what’s published in journals as gospel. For example, here’s what scientists might really mean when they pontificate:
A doctor in a white lab coat stands at the pearly gates. The voice of God booms: “And your good deeds?” The man responds: “Well, as a dermatologist, I’ve been warning people that sunlight will kill them and that it’s as deadly as smoking.”
